Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerwin

Showing results (971-980 of 984) with videos related to

Pageof 99
Sort By:
Neurology|May 24, 2024
Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid HemorrhageMaud A Tjerkstra, René Post, Menno R Germans, et al.
Cancer Medicine|August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood|September 15, 2020
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemiaGeoffrey L Uy, Ibrahim Aldoss, Matthew C Foster, et al.
Blood Advances|May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Lancet (London, England)|December 28, 2020
Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trialRené Post, Menno R Germans, Maud A Tjerkstra, et al.
Neurology|October 20, 2022
Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA TrialMaud A Tjerkstra, René Post, Menno R Germans, et al.
The New England Journal of Medicine|April 17, 2009
Genomewide association studies of strokeM Arfan Ikram, Sudha Seshadri, Joshua C Bis, et al.
Blood Advances|February 22, 2021
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trialBob Löwenberg, Thomas Pabst, Johan Maertens, et al.
ACS Nano|March 10, 2025
Interfacing with the Brain: How Nanotechnology Can ContributeAbdullah A A Ahmed, Nuria Alegret, Bethany Almeida, et al.
Biology Letters|September 20, 2023
Greater male variability in daily energy expenditure develops through pubertyLewis G Halsey, Vincent Careau, Philip N Ainslie, et al.
Pageof 99

Showing results (971-980 of 984) with videos related to

Sort By:
Pageof 99
Neurology|May 24, 2024
Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid HemorrhageMaud A Tjerkstra, René Post, Menno R Germans, et al.
Cancer Medicine|August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood|September 15, 2020
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemiaGeoffrey L Uy, Ibrahim Aldoss, Matthew C Foster, et al.
Blood Advances|May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Lancet (London, England)|December 28, 2020
Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trialRené Post, Menno R Germans, Maud A Tjerkstra, et al.
Neurology|October 20, 2022
Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA TrialMaud A Tjerkstra, René Post, Menno R Germans, et al.
The New England Journal of Medicine|April 17, 2009
Genomewide association studies of strokeM Arfan Ikram, Sudha Seshadri, Joshua C Bis, et al.
Blood Advances|February 22, 2021
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trialBob Löwenberg, Thomas Pabst, Johan Maertens, et al.
ACS Nano|March 10, 2025
Interfacing with the Brain: How Nanotechnology Can ContributeAbdullah A A Ahmed, Nuria Alegret, Bethany Almeida, et al.
Biology Letters|September 20, 2023
Greater male variability in daily energy expenditure develops through pubertyLewis G Halsey, Vincent Careau, Philip N Ainslie, et al.
Pageof 99